Travaux scientifiques

Doç. Dr. Muhammed Mustafa Atcı

72 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0398 PMID 34323116 2 citations (Europe PMC) Source : OpenAlex

  2. Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study

    European Journal of Breast Health, 2021

    DOI 10.4274/ejbh.galenos.2020.6346 PMID 33870111 11 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  3. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00608-y PMID 33651265 11 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  4. Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.12.1433 PMID 34794283 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  5. The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy

    Cureus, 2021

    DOI 10.7759/cureus.14639 PMID 34046274 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  6. Factors affecting survival in retroperitoneal sarcomas treated with upfront surgery: A real-world study by Turkish Oncology Group

    Van Yüzüncü Yıl University Academic Data Management System, 2021

    DOI 10.4999/uhod.215190 2 citations (OpenAlex) Source : OpenAlex

  7. Effect of type 2 diabetes mellitus on survival in metastatic pancreatic cancer

    Journal of Surgery and Medicine, 2021

    DOI 10.28982/josam.840948 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  8. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

    Tumori Journal, 2021

    DOI 10.1177/03008916211037739 PMID 34365852 5 citations (Europe PMC) Source : OpenAlex

  9. Impact of Coronaphobia on Treatment and Follow-Up Compliance of Cancer Patients

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0020 PMID 33880932 4 citations (Europe PMC) Source : OpenAlex

  10. Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck

    Cancer Chemotherapy and Pharmacology, 2021

    DOI 10.1007/s00280-021-04328-9 PMID 34312705 1 citation (Europe PMC) Source : OpenAlex

  11. La correlación entre los marcadores tumorales y los hallazgos de Ga-68DOTA-TATE PET/TC en pacientes con cáncer medular de tiroides avanzado

    Revista Española de Medicina Nuclear e Imagen Molecular, 2021

    DOI 10.1016/j.remn.2020.03.012 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  12. Assessment of abuse and related factors in older patients with cancer

    Supportive Care in Cancer, 2021

    DOI 10.1007/s00520-021-06391-7 PMID 34213643 1 citation (Europe PMC) Source : OpenAlex

  13. Predictive Importance of Vitamin D on Response to Neoadjuvant Chemotherapy in Turkish Patients with Locally Advanced Hormone Receptor Positive Breast Cancer

    Eurasian Journal of Medical Investigation, 2021

    DOI 10.14744/ejmi.2021.99947 1 citation (OpenAlex) Source : OpenAlex

  14. Determining the Current Situation of Geriatric Oncology in Turkey: A Survey of Medical Oncologists

    Journal of Oncological Sciences, 2021

    DOI 10.37047/jos.2020-80824 Texte intégral en libre accèsSource : OpenAlex

  15. Tiroid Bezi ve Hastalıklarına Multidisipliner Yaklaşım

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.224 Texte intégral en libre accèsSource : OpenAlex

  16. Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis.

    PubMed, 2020

    PMID 33099936 10 citations (Europe PMC) Source : OpenAlex

  17. The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155219898504 PMID 31955700 3 citations (Europe PMC) Source : OpenAlex

  18. The conversion of RAS status in metastatic colorectal cancer patients after first‐line biological agent treatment

    Colorectal Disease, 2020

    DOI 10.1111/codi.15389 PMID 33002301 3 citations (Europe PMC) Source : OpenAlex

  19. The Effect of Body Mass Index on Treatment Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Platinum-Based Therapy

    Nutrition and Cancer, 2020

    DOI 10.1080/01635581.2020.1801774 PMID 32748654 5 citations (Europe PMC) Source : OpenAlex

  20. The correlation between tumor markers and Ga-68 DOTA-TATE PET/CT findings in patients with advanced medullary thyroid cancer

    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2020

    DOI 10.1016/j.remnie.2020.04.005 PMID 33451923 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  21. Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis.

    PubMed, 2019

    PMID 31786840 5 citations (Europe PMC) Source : OpenAlex

  22. The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status

    Journal of Oncological Sciences, 2019

    DOI 10.1016/j.jons.2019.08.003 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex